Your browser doesn't support javascript.
loading
Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis.
You, Hongjuan; Yuan, Dongchen; Bi, Yanwei; Zhang, Ning; Li, Qi; Tu, Tao; Wei, Xiao; Lian, Qi; Yu, Tong; Kong, Delong; Yang, Xiaoying; Liu, Xiangye; Liu, Xiaomei; Kong, Fanyun; Zheng, Kuiyang; Tang, Renxian.
Afiliación
  • You H; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
  • Yuan D; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
  • Bi Y; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
  • Zhang N; Clinical Laboratory, Xuzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Xuzhou, Jiangsu, People's Republic of China.
  • Li Q; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
  • Tu T; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
  • Wei X; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
  • Lian Q; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
  • Yu T; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
  • Kong D; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
  • Yang X; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
  • Liu X; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
  • Liu X; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
  • Kong F; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
  • Zheng K; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China. kong.fanyun@163.com.
  • Tang R; Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
Cell Commun Signal ; 19(1): 33, 2021 03 15.
Article en En | MEDLINE | ID: mdl-33722250
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vimentina / Transactivadores / Carcinoma Hepatocelular / Proteínas del Citoesqueleto / Proteínas Adaptadoras Transductoras de Señales / Proteínas Reguladoras y Accesorias Virales / Transición Epitelial-Mesenquimal / Proteínas con Dominio LIM / Carcinogénesis / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vimentina / Transactivadores / Carcinoma Hepatocelular / Proteínas del Citoesqueleto / Proteínas Adaptadoras Transductoras de Señales / Proteínas Reguladoras y Accesorias Virales / Transición Epitelial-Mesenquimal / Proteínas con Dominio LIM / Carcinogénesis / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2021 Tipo del documento: Article